OPKO HEALTH INC. - COMMON STOCK

NetDania - New 12 months High: OPKO HEALTH INC. - COMMON STOCK

05 Mar 2025 09:52:19 By NetDania Notify

NetDania - New 12 months High: OPKO HEALTH INC. - COMMON STOCK

04 Mar 2025 11:11:28 By NetDania Notify

NetDania - New 12 months High: OPKO HEALTH INC. - COMMON STOCK

28 Feb 2025 09:52:41 By NetDania Notify

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

27 Feb 2025 16:10:15 By Nasdaq GlobeNewswire

OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025

13 Feb 2025 16:05:00 By Nasdaq GlobeNewswire

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

09 Jan 2025 11:45:00 By Nasdaq GlobeNewswire

OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck

07 Jan 2025 08:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: OPKO HEALTH INC. - COMMON STOCK

12 Dec 2024 11:21:35 By NetDania Notify

OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference

20 Nov 2024 08:00:00 By Nasdaq GlobeNewswire

OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results

07 Nov 2024 16:05:11 By Nasdaq GlobeNewswire

OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024

29 Oct 2024 16:05:00 By Nasdaq GlobeNewswire

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

07 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development

23 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: OPKO HEALTH INC. - COMMON STOCK

17 Sep 2024 11:54:13 By NetDania Notify

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

07 Aug 2024 16:06:35 By Nasdaq GlobeNewswire

OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024

01 Aug 2024 16:05:00 By Nasdaq GlobeNewswire

OPKO Health Announces $100 Million Share Repurchase Program

18 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments

17 Jul 2024 16:14:57 By Nasdaq GlobeNewswire

OPKO Health to Participate in the Jefferies Global Healthcare Conference

31 May 2024 10:49:15 By Nasdaq GlobeNewswire

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results

07 May 2024 16:05:00 By Nasdaq GlobeNewswire